Malaysia has launched its first Lung Cancer Immunotherapy (IO) Treatment Diary, developed by MSD and the Lung Cancer Network Malaysia (LCNM). The diary helps patients understand their diagnosis, track symptoms, and engage actively with their healthcare teams.
Malaysia Launches Lung Cancer IO Treatment Diary
It supports Malaysia’s WHO-backed commitment to integrated lung health, addressing the fact that 95% of lung cancer cases are detected at advanced stages. With tools for side-effect recognition, progress tracking, and appointment preparation, the diary empowers patients to manage their journey beyond hospital visits.
Distributed free nationwide, it aims to improve treatment continuity and outcomes by bridging gaps in patient education and communication.
Follow us on:
Read More News at #latestmalaysia #BusinessNews and #WorldFuture
